| A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment | 2021-10-07 | 2023-06-15 | |
| Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata | 2020-07-29 | 2023-06-07 | |
| Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders | 2022-05-05 | 2023-05-18 | 2024-04-12 |
| Trial for Treatment Refractory Trigeminal Neuralgia | 2019-06-25 | 2023-05-11 | 2024-05-07 |
| Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Women | 2022-08-12 | 2023-04-27 | 2024-04-25 |
| A Study of PF-06873600 in People With Cancer | 2018-03-07 | 2023-04-05 | |
| A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. | 2018-04-05 | 2023-02-23 | 2024-02-21 |
| A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS) | 2018-10-15 | 2023-02-14 | 2024-02-01 |
| The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients | 2021-04-28 | 2023-02-12 | 2024-02-12 |
| A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) | 2018-05-02 | 2023-02-09 | 2024-01-29 |
| Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria | 2020-12-25 | 2023-01-23 | 2024-01-08 |
| A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia | 2020-12-02 | 2023-01-16 | 2024-01-15 |
| Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants. | 2020-01-14 | 2022-12-30 | 2023-12-30 |
| Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia | 2021-12-24 | 2022-12-16 | 2023-12-11 |
| A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B | 2019-07-29 | 2022-11-16 | 2023-11-01 |
| A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. | 2017-04-24 | 2022-10-25 | 2023-06-20 |
| A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation | 2018-04-17 | 2022-10-13 | 2023-12-18 |
| Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age | 2022-04-20 | 2022-10-05 | |
| Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC | 2017-12-18 | 2022-10-03 | 2023-09-21 |
| A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis | 2020-12-15 | 2022-09-30 | 2023-09-29 |
| Voxelotor Neurocognitive Function Study | 2022-06-24 | 2022-09-30 | 2024-04-08 |
| An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer | 2019-06-04 | 2022-09-22 | 2023-09-18 |
| A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients | 2019-07-01 | 2022-09-21 | 2023-09-18 |
| A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction | 2021-12-28 | 2022-09-19 | 2023-09-18 |
| Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection | 2021-10-01 | 2022-09-15 | 2023-09-11 |
| Actigraphy Improvement With Voxelotor (ActIVe) Study | 2020-12-21 | 2022-09-08 | 2023-09-15 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants | 2020-05-20 | 2022-09-02 | 2023-08-30 |
| A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis | 2021-11-03 | 2022-09-02 | 2023-08-30 |
| 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants | 2020-05-21 | 2022-08-31 | 2023-05-18 |
| A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention | 2021-05-20 | 2022-08-23 | 2023-08-18 |
| Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN) | 2020-12-25 | 2022-08-03 | 2023-08-02 |
| Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). | 2021-08-25 | 2022-07-25 | 2023-07-20 |
| MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age | 2020-06-17 | 2022-07-24 | 2023-03-22 |
| MagnetisMM-3: Study Of Elranatamab (PF-06863135) Monotherapy in Participants With Multiple Myeloma Who Are Refractory to at Least One PI, One IMiD and One Anti-CD38 mAb | 2021-02-02 | 2022-06-17 | 2023-06-15 |
| A Study In Adults With Moderate To Severe Dermatomyositis | 2018-01-23 | 2022-05-27 | 2023-05-26 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan | 2021-06-14 | 2022-05-13 | 2023-05-10 |
| Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen | 2020-04-25 | 2022-04-29 | 2024-04-05 |
| A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection | 2021-09-09 | 2022-04-12 | 2023-04-11 |
| Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age | 2020-12-04 | 2022-04-06 | 2023-04-04 |
| Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age | 2021-10-21 | 2022-04-04 | 2023-03-17 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants | 2020-09-16 | 2022-04-02 | 2023-03-30 |
| Study of Pharmacodynamics and Safety of DGAT2i and ACCi Coadministered in Participants With Sponsor-defined Presumed Non Alcoholic Steatohepatitis | 2020-08-10 | 2022-03-31 | 2023-03-20 |
| Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors | 2018-06-18 | 2022-03-28 | 2023-03-22 |
| Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population | 2021-03-08 | 2022-03-25 | 2023-03-24 |
| TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE | 2020-07-29 | 2022-02-07 | 2023-02-06 |
| An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis | 2019-04-30 | 2022-01-27 | 2023-01-05 |
| A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis | 2019-09-12 | 2022-01-19 | 2022-12-20 |
| A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa | 2019-12-02 | 2022-01-10 | 2022-12-24 |
| PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA | 2020-09-15 | 2022-01-04 | 2022-10-17 |
| Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) | 2018-07-19 | 2021-12-22 | 2022-12-06 |